Whittier Trust CO Of Nevada Inc Abbott Laboratories Transaction History

Whittier Trust CO Of Nevada Inc

$3.83 Billion
Q3 2024

A detailed history of Whittier Trust CO Of Nevada Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Whittier Trust CO Of Nevada Inc holds 181,160 shares of ABT stock, worth $20.7 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

181,160

Previous 179,555 0.89%

Holding current value

$20.7 Million

Previous $18.7 Million 10.7%

% of portfolio

0.54%

Previous 0.52%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$100.07 - $118.13 $160,612 - $189,598	1,605 Added 0.89%	181,160 $20.7 Million
Q2 2024 Jul 26, 2024	SELL	$100.73 - $112.44 $160,059 - $178,667	-1,589 Reduced 0.88%	179,555 $18.7 Million
Q1 2024 May 02, 2024	BUY	$109.52 - $120.96 $581,989 - $642,781	5,314 Added 3.02%	181,144 $20.6 Million
Q4 2023 Jan 11, 2024	SELL	$90.19 - $110.4 $113,909 - $139,435	-1,263 Reduced 0.71%	175,830 $19.4 Million
Q3 2023 Oct 27, 2023	SELL	$95.53 - $114.62 $100,019 - $120,007	-1,047 Reduced 0.59%	177,093 $17.2 Million
Q2 2023 Jul 24, 2023	SELL	$100.78 - $112.29 $34,567 - $38,515	-343 Reduced 0.19%	178,140 $19.4 Million
Q1 2023 Apr 21, 2023	SELL	$96.86 - $114.01 $1.37 Million - $1.61 Million	-14,121 Reduced 7.33%	178,483 $18.1 Million
Q4 2022 Jan 25, 2023	BUY	$95.06 - $111.52 $80,991 - $95,015	852 Added 0.44%	192,604 $0
Q3 2022 Oct 21, 2022	BUY	$96.76 - $112.03 $320,856 - $371,491	3,316 Added 1.76%	191,752 $18.6 Million
Q2 2022 Jul 28, 2022	BUY	$102.07 - $123.37 $573,020 - $692,599	5,614 Added 3.07%	188,436 $20.5 Million
Q1 2022 Apr 29, 2022	BUY	$114.02 - $139.04 $1.1 Million - $1.34 Million	9,607 Added 5.55%	182,822 $21.6 Million
Q4 2021 Jan 19, 2022	BUY	$115.53 - $141.46 $596,827 - $730,782	5,166 Added 3.07%	173,215 $24.4 Million
Q3 2021 Nov 01, 2021	BUY	$116.66 - $129.06 $284,300 - $314,519	2,437 Added 1.47%	168,049 $19.9 Million
Q2 2021 Jul 29, 2021	SELL	$105.79 - $124.53 $175,822 - $206,968	-1,662 Reduced 0.99%	165,612 $19.2 Million
Q1 2021 Apr 26, 2021	BUY	$108.84 - $128.23 $749,798 - $883,376	6,889 Added 4.3%	167,274 $20 Million
Q4 2020 Jan 29, 2021	BUY	$105.0 - $114.42 $22,260 - $24,257	212 Added 0.13%	160,385 $17.6 Million
Q3 2020 Oct 30, 2020	SELL	$91.64 - $111.29 $52,876 - $64,214	-577 Reduced 0.36%	160,173 $17.4 Million
Q2 2020 Jul 10, 2020	BUY	$76.57 - $98.0 $1.32 Million - $1.69 Million	17,262 Added 12.03%	160,750 $14.7 Million
Q1 2020 Apr 27, 2020	BUY	$62.82 - $91.86 $471,464 - $689,409	7,505 Added 5.52%	143,488 $11.3 Million
Q4 2019 Jan 31, 2020	SELL	$78.51 - $87.4 $1.23 Million - $1.36 Million	-15,606 Reduced 10.29%	135,983 $11.8 Million
Q3 2019 Oct 18, 2019	BUY	$81.84 - $88.74 $206,891 - $224,334	2,528 Added 1.7%	151,589 $12.7 Million
Q2 2019 Jul 23, 2019	SELL	$72.88 - $85.0 $144,010 - $167,960	-1,976 Reduced 1.31%	149,061 $12.5 Million
Q1 2019 Apr 29, 2019	SELL	$66.22 - $80.06 $516,118 - $623,987	-7,794 Reduced 4.91%	151,037 $12.1 Million
Q4 2018 Feb 07, 2019	SELL	$65.56 - $74.27 $161,408 - $182,852	-2,462 Reduced 1.53%	158,831 $11.5 Million
Q3 2018 Oct 23, 2018	SELL	$60.81 - $73.36 $9,060 - $10,930	-149 Reduced 0.09%	161,293 $11.8 Million
Q2 2018 Jul 27, 2018	BUY	$57.57 - $63.54 $1.09 Million - $1.21 Million	18,972 Added 13.32%	161,442 $9.85 Million
Q2 2018 Jul 20, 2018	SELL	$57.57 - $63.54 $1.01 Million - $1.12 Million	-17,610 Reduced 11.0%	142,470 $5.83 Million
Q1 2018 May 01, 2018	BUY	$56.27 - $63.62 $129,927 - $146,898	2,309 Added 1.46%	160,080 $9.59 Million
Q4 2017 Feb 07, 2018	BUY	$53.68 - $57.47 $577,650 - $618,434	10,761 Added 7.32%	157,771 $9 Million
Q3 2017 Oct 23, 2017	BUY	$48.06 - $53.64 $7.07 Million - $7.89 Million	147,010	147,010 $7.84 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Whittier Trust CO Of Nevada Inc, based on Form 13F filings with the SEC.

News

Stay updated on Whittier Trust CO Of Nevada Inc with notifications on news.

Account

Whittier Trust CO Of Nevada Inc Abbott Laboratories Transaction History